Department of Orthopedics, Deaconess University Hospital, Bergen, Norway.
Department of Orthopedics, Aleris Nesttun Hospital, Bergen, Norway.
Cartilage. 2020 Jan;11(1):71-76. doi: 10.1177/1947603518783482. Epub 2018 Jun 21.
To investigate survival of cartilage repair in the knee by microfracture (MFX; = 119) or mosaicplasty osteochondral autograft transfer (OAT; = 84).
For survival analyses, "failure" was defined as the event of a patient reporting a Lysholm score <65 or undergoing an ipsilateral knee replacement. The Kaplan-Meier method was used for construction of a survival functions plot for the event "failure." Log rank (Mantel-Cox) test was used for comparison of survival distributions in the 2 groups.
The long-term failure rate (62% overall) was significantly higher in the MFX group (66%) compared with the OAT group (51%, = 0.01). Furthermore, the mean time to failure was significantly shorter ( < 0.001) in the MFX group, 4.0 years (SD 4.1) compared with the OAT group, 8.4 years (SD 4.8). In the OAT group, the survival rate stayed higher than 80% for the first 7 years, and higher than 60% for 15 years, while the survival rate dropped to less than 80% within 12 months, and to less than 60% within 3 years in the MFX group, log rank (Mantel-Cox) 20.295 ( < 0.001). The same pattern was found in a subgroup of patients ( = 134) of same age (<51 years) and size of treated lesion (<500 mm), log rank (Mantel-Cox) 10.738 ( = 0.001). The nonfailures (48%) were followed for median 15 yeas (1-18 years).
MFX articular cartilage repairs failed more often and earlier than the OAT repairs, both in the whole cohort and in a subgroup of patients matched for age and size of treated lesion, indicating that the OAT repair is the more durable.
Therapeutic study, Level III.
通过微骨折术(MFX;n=119)或马赛克plasty 骨软骨自体移植物移植(OAT;n=84)来研究膝关节软骨修复的存活率。
对于生存分析,“失败”定义为患者报告 Lysholm 评分<65 或同侧膝关节置换的事件。Kaplan-Meier 方法用于构建事件“失败”的生存函数图。对数秩(Mantel-Cox)检验用于比较两组的生存分布。
MFX 组(66%)的长期失败率(总体为 62%)显著高于 OAT 组(51%,=0.01)。此外,MFX 组的平均失败时间明显更短(<0.001),4.0 年(SD 4.1)与 OAT 组的 8.4 年(SD 4.8)相比。在 OAT 组中,生存率在前 7 年保持在 80%以上,在 15 年内保持在 60%以上,而在 MFX 组中,生存率在 12 个月内降至 80%以下,在 3 年内降至 60%以下,对数秩(Mantel-Cox)20.295(<0.001)。在年龄(<51 岁)和治疗病变大小(<500mm)相同的患者亚组(n=134)中也发现了相同的模式,对数秩(Mantel-Cox)10.738(=0.001)。未失败(48%)患者中位随访 15 年(1-18 年)。
MFX 关节软骨修复术比 OAT 修复术更容易失败,且失败时间更早,无论是在整个队列中还是在年龄和治疗病变大小匹配的患者亚组中,这表明 OAT 修复术更持久。
治疗研究,III 级。